Medium to long-term echo follow-up after ventricular septal defect device closure

Rahmath, Muhammed Riyas K; Numan, Mohammed T; Dilawar, Muhammad

doi:10.1177/0218492316645746

Cited by 10 publications

(15 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A residual shunt rate of 3 to 29% has been reported in the past decades [4,13,22,26,27]. The overall residual shunt rate of 13.8% in our longterm cohort seems to be moderate and tolerable, but we have to emphasize that residual shunts were small and did caused relevant volume load over time.…”

Section: Residual Shuntmentioning

confidence: 41%

“…However, the success rate depends on the relation of VSD diameter and height/ weight of the child, as well as on the distance to the aortic and tricuspid valve [20]. Although relevant residual shunting and bradyarrhythmia (especially cAVB) are major concerns, only limited data are available with long-term follow-up for these issues [10,19,[21][22][23]. In order to demonstrate the safety and performance of VSD devices in the long run, we focused on patients with at least 1-year follow-up after the procedure, since many publications only include short-or middle-term followup data [8,[23][24][25].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients

et al. 2020

View full text Add to dashboard Cite

Interventional closure of congenital ventricular septal defects (VSD) is recording a continuous rise in acceptance. Complete atrioventricular block (cAVB) and residual shunting are major concerns during follow-up, but long-term data for both are still limited. We retrospectively evaluated the outcome of patients with interventional VSD closure and focused on long-term results (> 1 year follow-up). Transcatheter VSD closures were performed between 1993 and 2015, in 149 patients requiring 155 procedures (104 perimembranous, 29 muscular, 19 residual post-surgical VSDs, and 3 with multiple defects). The following devices were used: 65 × Amplatzer™ Membranous VSD Occluder, 33 × Duct Occluder II, 27 × Muscular VSD Occluder, 3 × Duct Occluder I, 24 × PFM-Nit-Occlud®, and 3 × Rashkind-Occluder. The median age at time of implantation was 6.2 (0.01–66.1) years, median height 117 (49–188) cm, and median weight 20.9 (3.2–117) kg. Median follow-up time was 6.2 (1.1–21.3) years and closure rate was 86.2% at last follow-up. Complications resulting in device explantation include one case of cAVB with a Membranous VSD occluder 7 days after implantation and four cases due to residual shunt/malposition. Six (4%) deaths occurred during follow-up with only one procedural related death from a hybrid VSD closure. Overall, our reported results of interventional VSD closure show favorable outcomes with only one (0.7%) episode of cAVB. Interventional closure offers a good alternative to surgical closure and shows improved performance by using softer devices. However, prospective long-term data in the current era with different devices are still mandatory to assess the effectiveness and safety of this procedure.

show abstract

Section: Residual Shuntmentioning

confidence: 41%

Section: Discussionmentioning

confidence: 99%

Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Research has shown that with the continuous upgrading of interventional devices and with clinicians becoming increasingly skilled in terms of the performance of device closure for VSDs, people expect increasing therapeutic effects from device closure for VSDs. [2][3][4][5][6][7][8] However, while paying attention to the therapeutic effect of VSD closure, we should also pay attention to the postoperative HRQoL of patients to better track the prognosis of this disease. HRQoL is not only physical but also psychological and even social.…”

Section: Discussionmentioning

confidence: 99%

“…[14][15][16] As two safe and effective treatments for VSDs, transthoracic and transcatheter device closure treatments have been increasingly applied in the clinic. [2][3][4][5][6][7][8]17) In some existing studies, researchers have explored HRQoL in patients with VSD after either thoracic or catheter closure. In most of these studies, the objective was to compare the changes in HRQoL in patients before and after treatment or to compare patients' HRQoL with that of healthy peers during the same period to explore the positive effects of treatment.…”

Section: Discussionmentioning

confidence: 99%

“…2) In recent years, transthoracic device closure for VSDs has been widely used and has produced good results, especially in China. 3,4) Many studies have examined the postoperative prognosis of patients with VSDs, but most of them have focused on postoperative complications and cardiac function 5,6) and have paid less attention to the health-related quality of life (HRQoL) of patients. There has been no research comparing the postoperative HRQoL in Chinese patients undergoing transthoracic and transcatheter device closure for VSDs.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Health-Related Quality of Life in Adults Undergoing Transthoracic and Transcatheter Device Closure for Ventricular Septal Defects

Kim

Huang

et al. 2020

Int. Heart J.

View full text Add to dashboard Cite

Mid-term results of transcatheter closure of ventricular septal defect using Nit-Occlud Lê ventricular septal defect coil, single-center experience

Shedoudy

El-Doklah

2019

Journal of the Saudi Heart Association

View full text Add to dashboard Cite

ObjectivesTo assess safety, efficacy and follow-up results of transcatheter closure of ventricular septal defect (VSD) using Nit-Occlud_ Lê VSD Coil (pfm medical, KÖln, Germany).BackgroundTranscatheter VSD closure has achieved encouraging results but more follow-up studies are needed.Patients and methodsBetween January 2012 and December 2013 in the cardiology department, Tanta University Hospital, Tanta, Egypt, 80 patients underwent percutaneous VSD closure using Nit-Occlud_ Lê VSD Coil. Early and mid- term follow-up was done for 3 years, follow-up was concluded in 2016.ResultsThe mean age of patients was 5.34 ± 3 years, and their mean weight was 17.24 ± 8.17 kg. Overall, 77 of 80 patients had perimembranous VSD with aneurysmal tissue; eight had multiple right ventricular exits, 14 had deficient aortic rim, two had high outlet muscular, and one had Gerbode defect. The procedure was successful in 98.75% of patients, and was aborted in one patient because of the development of complete heart block and the coil had to be removed. The mean procedure time was 104.98 ± 9.50 minutes. The mean fluoroscopy time was 30.58 ± 2.79 minutes. The immediate complete occlusion rate was 62%, which increased to 82.3% on the second day, and 94.9% by the 3rd month, and 97.5% by 1 year. There was a significant decrease in mitral incompetence after 6 months of follow-up (p = 0.002), and only one patient had trivial aortic incompetence prior to the procedure that remained the same during follow-up period.ConclusionUsing Nit-Occlud_ Lê VSD-Coil to close VSD is safe and feasible in VSDs with various morphology.

show abstract

Medium to long-term echo follow-up after ventricular septal defect device closure

Abstract: Transcatheter closure of perimembranous and muscular ventricular septal defects is effective, however, these patients need to be followed up regularly to detect device-related problems, specifically, aortic and tricuspid valve regurgitation.

Cited by 10 publications

References 20 publications

Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients

Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients

Comparison of Health-Related Quality of Life in Adults Undergoing Transthoracic and Transcatheter Device Closure for Ventricular Septal Defects

Mid-term results of transcatheter closure of ventricular septal defect using Nit-Occlud Lê ventricular septal defect coil, single-center experience

Contact Info

Product

Resources

About